PHYTOMEDICINES AND GLOBAL HEALTH: AN ETHICAL ANALYSIS OF HERBAL MEDICINE

Authors

  • Keshav Kumar Gupta Vijay Sudha College of Pharmacy, Sidharth Nagar, Uttar Pradesh, India

Keywords:

Global Health, traditional herbal medicine

Abstract

Governments, international agencies and corporations are increasingly investing in traditional herbal medicine research. Yet little literature addresses ethical challenges in this research. In this paper, we apply concepts in a comprehensive ethical framework for clinical research to international traditional herbal medicine research. We examine in detail three key, underappreciated dimensions of the ethical framework in which particularly difficult questions arise for international herbal medicine research: social value, scientific validity and favourable risk–benefit ratio. Significant challenges exist in determining shared concepts of social value, scientific validity and favourable risk–benefit ratio across international research collaborations. However, we argue that collaborative partnership, including democratic deliberation, offers the context and process by which many of the ethical challenges in international herbal medicine research can, and should be, resolved. By “cross-training” investigators, and investing in safety-monitoring infrastructure, the issues identified by this comprehensive framework can promote ethically sound international herbal medicine research that contributes to global health.

References

WHO (2003). SARS. clinical trials on treatment using a combination of traditional chinese medicine and western medicine Geneva: pp. 53-61.

WHO(2002). WHO traditional medicine strategy 2002–2005 Geneva

Willcox, M. L., & Bodeker, G. (2004). Traditional herbal medicines for malaria. Bmj, 329(7475), 1156-1159.

Zamiska, N. (2006). On the trail of ancient cures. Wall Street Journal, 15, B1-B12.

Novartis eyes traditional Chinese medicine United Press International. Available from: http://www.upi.com/NewsTrack/view.php?StoryID=20061106-022125-5205r [accessed on 1 August 2007].

Zaslawski, C., & Davis, S. (2005). The ethics of complementary and alternative medicine research: a case study of Traditional Chinese Medicine at the University of Technology, Sydney. Monash Bioethics Review, 24(3), S52-S61.

Nyika, A. (2007). Ethical and regulatory issues surrounding African traditional medicine in the context of HIV/AIDS. Developing World Bioethics, 7(1), 25-34.

Emanuel, E. J., Wendler, D., Killen, J., & Grady, C. (2004). What makes clinical research in developing countries ethical? The benchmarks of ethical research. The Journal of infectious diseases, 189(5), 930-937.

Miller, W. C., Ford, C. A., Morris, M., Handcock, M. S., Schmitz, J. L., Hobbs, M. M., ... & Udry, J. R. (2004). Prevalence of chlamydial and gonococcal infections among young adults in the United States. Jama, 291(18), 2229-2236.

Chong, W. (2006). China launches traditional medicine safety research. Science and Development Network.

Pefile S(2006). South African legislation on traditional medicine Science and Development Network; 2005. Available from: http://www.scidev.net/en/policy-briefs/south-african-legislation-on-traditional-medicine.html [accessed on 11 December 2006].

White J. Public address: Overview of NCI’s TCM-related research presented at Traditional Chinese Medicine and Cancer Research: Fostering Collaboration; Advancing the Science, April10,2006 Office of Cancer Complementary and Alternative Medicine (OCCAM).

Serbulea M(2005). Old meets new in West Africa’s medicine mix Science and Development Network; Available from: http://www.scidev.net/en/features/old-meets-new-in-west-africas-medicine-mix.html [accessed on 31 January 2007].

Adelaja, A. (2006). Nigeria boosts research into traditional medicine. Science and Development Network: news, views and information about science and technology and the development world.

Linde, K., & Jonas, W. B. (1999). Evaluating complementary and alternative medicine: the balance of rigor and relevance. Essentials of Complementary and Alternative Medicine. Philadelphia: Lippincott, 57-71.

Turner, R. B., Bauer, R., Woelkart, K., Hulsey, T. C., & Gangemi, J. D. (2005). An evaluation of Echinacea angustifolia in experimental rhinovirus infections. New England Journal of Medicine, 353(4), 341-348.

Boli Z, Shuren L, Junping Z, Hongwu W(2003). Manifestation of symptoms in patients with SARS and analysis of the curative effect of treatment with integrated Traditional Chinese Medicine and Western medicine. In: SARS: clinical trials on treatment using a combination of Traditional Chinese Medicine and Western medicine Geneva: pp. 53-61.

Kaptchuk TJ(2000). The web that has no weaver: understanding Chinese medicine New York: Contemporary Books.

Macklin EA, Wayne PM, Kalish LA, Valaskatgis P, Thompson J, Pian-Smith MC, et al(2006). Stop hypertension with the acupuncture research program (SHARP): results of a randomized, controlled clinical trial. p838–45, doi: 10.1161/01.HYP.0000241090.28070.4c.

Zhao L, Chan K(2005). Building a bridge for integrating Chinese medicine into conventional healthcare: observations drawn from the development of the Chinese Quality of Life Instrument. Am J Chin Med. p. 897–902. doi: 10.1142/S0192415X05003533.

Downloads

Submitted

2023-07-24

Published

2023-07-23